Switch to:

Galena Biopharma Inc (GALE)Ownership Data

Short Interest History (%)

This is the historical short interest of Galena Biopharma Inc, as measured by the Short Percentage Of Float.

Date Short Interest
December 31, 201415.11
December 15, 201416.62
November 28, 201416.55
November 14, 201416.8
October 31, 201416.75
October 15, 201418.03
September 30, 201417.9
September 15, 201417.87
August 29, 201417.58
August 15, 201418.51
July 31, 201419.07
July 15, 201418.77
June 30, 201417.93
June 13, 201422.36
May 30, 201422.21
May 15, 201422.75
April 30, 201422.58
April 15, 201431.21
March 31, 201431.21
March 14, 201428.86
February 28, 201427.41
February 14, 201426.79
January 31, 201422.99
January 15, 201425.2
December 31, 201322.75
December 13, 201319.43
November 29, 201319.16
November 15, 201320.12
October 31, 201319.04
October 15, 201318.44
September 30, 201317.49
September 13, 201316.9
August 30, 201316.85
August 15, 201317.07
July 31, 201317.29
July 15, 201317.47
June 28, 201314.92
June 14, 201314.27
May 31, 201313.57
May 15, 201314.63
April 30, 201314.11
April 15, 201316.77
March 28, 201316.93
March 15, 201315.85
February 28, 201316.59
February 15, 201316.14
January 31, 201315.14
January 15, 201313.61
December 31, 201211.55
December 14, 201212.34
November 30, 201210.92
November 15, 201211.48
October 31, 201211.78
October 15, 201211.17
September 28, 201211.03
September 14, 201210.96
August 31, 201211.49
August 15, 201211.27
July 31, 201210.61
July 13, 20128.33
June 29, 20128.07
June 15, 20126.94
May 31, 20126.56
May 15, 20126.2
April 30, 20124.44
April 13, 201216.45
March 30, 201217.52
March 15, 201211.72
February 29, 201210.32
February 15, 201210.77
January 31, 20127.06
January 13, 20126.19
December 30, 20116.33
December 15, 20117.08
November 30, 20117.18
November 15, 20117.61
October 31, 20117.65
October 14, 20118.19
September 30, 20115.67
September 15, 20118.77
August 31, 20118.88
August 15, 20118.59
July 29, 20118.49
July 15, 20118.57
June 30, 20118.33
June 15, 20118.47
May 31, 20116.8
May 13, 20115.43
April 29, 20114.18
April 15, 201123.23
March 31, 201116.72
March 15, 201117.91
February 28, 201125.86
February 15, 201124.03
January 31, 201118.81
January 14, 20119.57
December 31, 201015.49
December 15, 201012.02
November 30, 201010.55
November 15, 201010.34
October 29, 201010.03
October 15, 20108.71
September 30, 20106.61
September 15, 20104.3
August 31, 20104.18
August 13, 20104.5
July 30, 20104.62
July 15, 20104.77
June 30, 201010.64
June 15, 20108.62
May 28, 20105.08
May 14, 20104.98
April 30, 20105.75
April 15, 20104.43
March 31, 20103.15
March 15, 20103.37
February 26, 20103.31
February 12, 20103.33
January 29, 20103.14
January 15, 20102.94
December 31, 20092.63
December 15, 20090.29
November 30, 20090.28
November 13, 20090.24
October 30, 20090.24
October 15, 20090.31
September 30, 20090.36
September 15, 20090.41
August 31, 20090.42
August 14, 20090.41
July 31, 20090.68
July 15, 20090.56
June 30, 20090.58
June 15, 20090.57
May 29, 20090.55
May 15, 20090.51
April 30, 20090.49
April 15, 20090.47
March 31, 20090.49
March 13, 20090.52
February 27, 20090.54
February 13, 20090.54
January 30, 20090.51
January 15, 20090.51
December 31, 20080.51
December 15, 20080.51
November 28, 20080.31
November 14, 20080.53
October 31, 20080.54
October 15, 20080.6
September 30, 20080.61
September 15, 20080.35
August 29, 20080.17
August 15, 20080.17
July 31, 20080.42
July 15, 20080.48
June 30, 20080.62
June 13, 20081.42
May 30, 20081.43
May 15, 20081.47
April 30, 20081.47
April 15, 20081.8
March 31, 20082.4
March 14, 20083.71

Institutional Ownership History (%)

This the Institutional Ownership History of Galena Biopharma IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
December 31, 201416
November 30, 201416
October 31, 201416
September 30, 201417
August 31, 201417
July 31, 201417
June 30, 201428
May 31, 201427
April 30, 201427
March 31, 201419
February 28, 201421
January 31, 201424
December 31, 201319
November 30, 201317
October 31, 201317
September 30, 201316
August 31, 201316
July 31, 201316
June 30, 20138
May 31, 20136
April 30, 20136
March 31, 20133
February 28, 20136
January 31, 201310
December 31, 201210
November 30, 201210
October 31, 20123
September 30, 20123
August 31, 20124
July 31, 20124
June 30, 20124
May 31, 20123
April 30, 20123
March 31, 20123
February 29, 20127
January 31, 20128
December 31, 20116
November 30, 20116
October 31, 20116
September 30, 201113
July 31, 201115
June 30, 201114
May 31, 201113
April 30, 201118
March 31, 201121
February 28, 201121
January 31, 201119
December 31, 201019
November 30, 201015
October 31, 201014
September 30, 201014
August 31, 201014
July 31, 201018
June 30, 201013
May 31, 201013
April 30, 20108
March 31, 20108
February 28, 20108
January 31, 201017
December 31, 200917
November 30, 200917
October 31, 200914
September 30, 200921
August 31, 200921
July 31, 200924
June 30, 200917
May 31, 200917
April 30, 200917
March 31, 200917
February 28, 200917
January 31, 200918
December 31, 200817
November 30, 200817
October 31, 200818
September 30, 200817
August 31, 200817
July 31, 200817
June 30, 200818
May 31, 200818
April 30, 200818
March 31, 200810
February 29, 200810
January 31, 200810

Insider ownership (%)

This is the historical insider ownership of Galena Biopharma Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
December 31, 20141
November 30, 20141
October 31, 20141
September 30, 20141
August 31, 20141
September 30, 20113
August 31, 20113
July 31, 20113
June 30, 20113
May 31, 20113
April 30, 20113
March 31, 20112
February 28, 20111
January 31, 20111
December 31, 20101
November 30, 20101
October 31, 20101
September 30, 20101
August 31, 20101
July 31, 20101
February 28, 20101
January 31, 20101
April 30, 20091
March 31, 20091
February 28, 20092

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Mark W. Schwartz, PhDEVP & COO415,9720.34%2015-01-16
Dr. Mark J. Ahn, PhDPresident & CEO116,2250.1%2014-06-30
Dr. Rudolph Nisi,M.D.Director23,500less than 0.1%2014-02-07
Sanford J. HillsbergDirector17,974less than 0.1%2014-01-30
Mr. Ryan DunlapN/A11,650less than 0.1%2015-01-16
Stephen S. GallikerDirector10,000less than 0.1%2014-02-03
Steven A. KriegsmanDirector5,000less than 0.1%2014-01-23
Mr. Kwang LeePrincipal Accounting Officer5,000less than 0.1%2011-12-07
Dr. Brian L. Hamilton,M.D.,PhDN/A2,461less than 0.1%2014-06-30

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
BlackRock Fund Advisors3,978,6412014-09-303.280.008,196,000
Vanguard Group, Inc.3,756,9332014-09-303.090.007,740,000
Vanguard Total Stock Mkt Idx2,016,6092014-12-311.660.003,045,080
iShares Russell 2000 (AU)2,007,8512015-01-221.800.013,292,876
State Street Corp1,726,5652014-09-301.420.003,555,000
Northern Trust Investments, N.A.1,297,5732014-09-301.070.002,673,000
Vanguard Extended Market Index Fund1,174,4622014-12-310.970.001,773,438
iShares Russell 2000 Growth896,9852015-01-220.800.021,471,055
Susquehanna Financial Group, LLLP706,0612014-09-300.580.001,454,000
Geode Capital Management, LLC705,4652014-09-300.580.001,453,000

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK